on 12 Mar 2024
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
913201799
Serial Number
97790196 filed on 10th Feb 2023
Registration Number
N/A
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmRead More
Pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
No 97790196
No Service/Collective Mark
No TM-2239-US-1
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 12th Mar 2024 | PUBLISHED FOR OPPOSITION |
| 12th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 21st Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 21st Feb 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 02th Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 10th Jan 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 09th Jan 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 09th Jan 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 29th Sep 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 29th Sep 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
